trofinetide

SAN DIEGO, U.S, Aug 28, 2026 Acadia Pharmaceuticals Inc. announced that the European Commission (EC) has granted marketing authorization...

SAN DIEGO, June 26, 2026 Acadia Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) of...

San Diego, California, USA, April 7, 2026 Broad U.S. Availability Expands Patient Access In a major advancement for rare...